Mehar Manku,Ian Osterloh,Pierre Wicker,Rene Braeckman,Paresh Soni
申请号：
US15791885
公开号：
US20180042883A1
申请日:
2017.10.24
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present disclosure provides methods for treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. In some embodiments, the method comprises lowering high sensitivity CRP (hs-CRP) levels in a subject including, for example, a subject with a HbA1c value of about 5.00%-8.50% or at least about 6.8%.
